Orexin receptor antagonists are on the market or under development for the treatment of insomnia and a number of other neuropsychiatric disorders. Currently, suvorexant, lemborexant and daridorexant, three dual orexin receptor antagonists (DORAs) have received market approval by regulatory authorities in the USA, Australia, Europe and/or Japan for the ...
Daniel Hoyer, Laura H. Jacobson
openaire +3 more sources
A New Positron Emission Tomography Probe for Orexin Receptors Neuroimaging. [PDF]
Bai P +7 more
europepmc +1 more source
Structural insights into the binding mode of the hypnotic drug vornorexant to orexin receptors. [PDF]
Mima M +4 more
europepmc +1 more source
Spatial mRNA expression patterns of orexin receptors in the dorsal hippocampus. [PDF]
Krause GM +2 more
europepmc +1 more source
In vivo photocontrol of orexin receptors with a nanomolar light-regulated analogue of orexin-B. [PDF]
Prischich D +10 more
europepmc +1 more source
Blockade of Orexin Receptors in the Posterior Paraventricular Nucleus of the Thalamus Prevents Stress-Induced Reinstatement of Reward-Seeking Behavior in Rats With a History of Ethanol Dependence. [PDF]
Matzeu A, Martin-Fardon R.
europepmc +1 more source
Mignot and Yanagisawa win Lasker prize for discovery of the role of orexins in wake, sleep, and narcolepsy. [PDF]
Saper CB.
europepmc +1 more source
To sleep and dream: Unraveling narcolepsy. [PDF]
Friedman JM.
europepmc +1 more source
Research Progress and Future Perspectives of Orexin Receptor Antagonists in Insomnia Therapy. [PDF]
Zhang Z, Zhu L, Gao Y, Ji C, Ling Y.
europepmc +1 more source

